tiprankstipranks
Kaneka Corporation (JP:4118)
:4118
Want to see JP:4118 full AI Analyst Report?

Kaneka (4118) Price & Analysis

0 Followers

4118 Stock Chart & Stats

¥4964.00
-¥17.00(-0.46%)
At close: 4:00 PM EST
¥4964.00
-¥17.00(-0.46%)

Bulls Say, Bears Say

Bulls Say
Sustained Revenue GrowthMulti-year revenue expansion indicates durable end-market demand and recurring customer relationships across the company’s businesses. Sustained top-line growth supports scale, reinvestment and pricing leverage, making earnings resilience likelier even if margins remain modest.
Diversified Product PortfolioA broad mix across specialty chemicals, polymers, food ingredients and life‑science materials reduces single-market cyclicality and allows cross-segment synergies. Diversification supports steadier revenue streams and lowers dependency on any one end market or commodity cycle.
Reasonable Balance SheetSteadily rising equity and moderate leverage provide financial flexibility for capex, qualifications and targeted M&A. A sane balance sheet lowers refinancing risk and preserves capacity to invest through cycles, supporting long-term operational continuity.
Bears Say
Modest Net MarginsLow net margins constrain the company’s ability to convert revenue gains into durable profit and retained earnings. With only modest bottom-line leverage, the business is more exposed to input-cost shocks and has less internal cash to fund growth or boost shareholder returns.
Volatile Free Cash FlowRepeated negative or near-zero free cash flow in several years implies heavy investment needs or working-capital swings. Weak FCF undermines debt reduction, dividend sustainability and capacity to self-fund strategic projects without issuing debt or equity.
Moderate Returns On CapitalMid-single-digit ROE signals below‑average capital efficiency for a specialty chemical group. Unless improved, such returns limit long-term shareholder value creation and mean the company must sustain higher growth or improve margins to justify reinvestment.

Kaneka News

4118 FAQ

What was Kaneka Corporation’s price range in the past 12 months?
Kaneka Corporation lowest stock price was ¥3810.00 and its highest was ¥5658.00 in the past 12 months.
    What is Kaneka Corporation’s market cap?
    Kaneka Corporation’s market cap is ¥324.99B.
      When is Kaneka Corporation’s upcoming earnings report date?
      Kaneka Corporation’s upcoming earnings report date is Aug 12, 2026 which is in 63 days.
        How were Kaneka Corporation’s earnings last quarter?
        Kaneka Corporation released its earnings results on May 14, 2026. The company reported ¥204.54 earnings per share for the quarter, beating the consensus estimate of N/A by ¥204.54.
          Is Kaneka Corporation overvalued?
          According to Wall Street analysts Kaneka Corporation’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Kaneka Corporation pay dividends?
            Kaneka Corporation pays a Semiannually dividend of ¥104 which represents an annual dividend yield of 3.41%. See more information on Kaneka Corporation dividends here
              What is Kaneka Corporation’s EPS estimate?
              Kaneka Corporation’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Kaneka Corporation have?
              Kaneka Corporation has 63,000,000 shares outstanding.
                What happened to Kaneka Corporation’s price movement after its last earnings report?
                Kaneka Corporation reported an EPS of ¥204.54 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.807%.
                  Which hedge fund is a major shareholder of Kaneka Corporation?
                  Currently, no hedge funds are holding shares in JP:4118
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Kaneka Corporation

                    Kaneka Corporation, established in Tokyo, Japan, in 1949, operates internationally as a diversified manufacturer providing a wide array of advanced materials and specialized products. Its core chemical business includes the production and global distribution of various polyvinyl chloride (PVC) formulations, such as crosslinked, paste, and chlorinated PVC, alongside acryl grafted-vinyl chloride copolymers. The company also supplies critical additives like impact modifiers, processing aids, specialty additives, and tougheners for thermosetting resins. Furthermore, their portfolio features advanced polymers including silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, biodegradable polymers, and engineering resins designed for injection molding, in addition to zero birefringence materials, acrylic films, and isobutylene-based thermoplastic elastomers. Beyond chemicals, Kaneka manufactures specialized foams and films, encompassing polypropylene and Kanelite foams, extruded polystyrene insulation, polyimide films, and transparent films for optical applications. Their material science expertise extends to high thermal conductive graphite sheets, multi-layer insulation, transparent conductive films, and transparent resins engineered for exceptional heat and light resistance. In the energy and innovative products sector, Kaneka offers photovoltaic power generation systems suitable for residential, public, and industrial installations. Other cutting-edge developments include eco-friendly fur, flame-retardant materials, hair accessories, novel materials, organic EL lighting panels, and biosurfactants. Their life sciences division delivers a comprehensive range of medical and pharmaceutical offerings, which include intervention and blood purification systems, gastroenterology intervention tools, diagnostic testing equipment, regenerative medicine and cell therapy solutions, and genetic diagnostics. Additionally, they provide low molecular pharmaceutical raw materials, affinity chromatography resins for monoclonal antibody purification, biopharmaceuticals, transdermal medicines, and innovative shock-absorbing innerwear. Lastly, Kaneka is a significant player in the food and nutrition industry. Their extensive product line features dairy products, margarines, fats and oils, whipping creams, fillings, baking essentials (baker's yeast, dough improvers), processed fruits, butter, shortening, cacao butter alternatives, various creams, frozen dough, spices, and antifreeze materials. They also supply pharmaceutical and supplemental nutrition solutions, such as coenzyme Q10, lactic-acid bacteria, and functional foodstuffs, alongside agricultural fertilizers.

                    Kaneka (4118) Earnings & Revenues

                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Daicel
                    DIC
                    Mitsui Chemicals
                    Nitto Denko
                    UBE Industries

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks